Limula was founded by Thomas Eaton, Yann Pierson.

Who are Limula's investors?

Limula's investors include LifeX Ventures, Verve Ventures, Zühlke Ventures, Oxford Seed Fund.

How much funding has Limula raised?

Limula has disclosed $6.8M raised across 1 of its 3 known rounds.

Where is Limula headquartered?

Limula is headquartered in Lausanne, CH.

Limula

Lausanne, CH · 6 known investors

Find your way into Limula

Paths you didn't know you had: your email and LinkedIn already hold routes to the Limula team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes. It serves cell therapy developers and manufacturers in the biotech and pharmaceutical industry, and is based in Switzerland.

Biotech Deep Tech Hardware Medical Devices

Founders & leadership

Thomas Eaton Founder & CEOThomas Eaton previously worked as a consultant and held an academic position at Oxford. He is Founder and CEO of Limula, a Switzerland-based company developing an automated platform for manufacturing cell and gene therapies.

Yann Pierson Founder & CTOYann Pierson holds a DPhil in Chemical Biology from the University of Oxford and previously served as a scientific advisor to EPFL's president. He co-founded Limula in 2020, where he has led the company and secured CHF 22 million in combined equity and non-dilutive funding.

Caroline BoudousquiéHead of Solutions

Olivier Waridel Head of OperationsWith over two decades of international business experience across Europe, North America, South America, and Asia, he has held roles in business development, product innovation, marketing, sales, quality, regulatory compliance, and general management.

Investors · 6

LifeX Ventures✓ confirmed by LimulaSan Franciscovia Inaki Berenguer · inferred

How we know: the company's own site · LifeX Ventures's portfolio page · a partner's Signal profile · funding news · drug-dev.com · Not right? Tell us

Verve Ventureslisted by Verve VenturesZürich · $300K – $2.2M

How we know: funding news · drug-dev.com · Not right? Tell us

Zühlke Ventureslisted by Zühlke VenturesZurich · $165K – $275K

How we know: Zühlke Ventures's portfolio page · funding news · drug-dev.com · Not right? Tell us

Oxford Seed FundreportedOxford · $19.1K – $127K

How we know: funding news · drug-dev.com · Not right? Tell us

Also in the syndicate · 2

Lichtsteiner FoundationW.A. de Vigier Foundation

Funding

SEC filings, press & company announcements

$6.8M disclosed across 1 of 3 rounds · 2024

$6.8Mseed roundMay 2024 · 3 sources
LifeX Ventures (lead), Lichtsteiner Foundation, Oxford Seed Fund, Verve Ventures, W.A. de Vigier Foundation, Zühlke Ventures
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Limula do?: Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes. It serves cell therapy developers and manufacturers in the biotech and pharmaceutical industry, and is based in Switzerland.
Who founded Limula?: Limula was founded by Thomas Eaton, Yann Pierson.
Who are Limula's investors?: Limula's investors include LifeX Ventures, Verve Ventures, Zühlke Ventures, Oxford Seed Fund.
How much funding has Limula raised?: Limula has disclosed $6.8M raised across 1 of its 3 known rounds.
Where is Limula headquartered?: Limula is headquartered in Lausanne, CH.